Related Experiment Videos
Essential myosin light chain as a target for caspase-3 in failing myocardium
Alessandra Moretti1, Hans-Jörg Weig, Thomas Ott
1I. Medizinische Klinik and Deutsches Herzzentrum, D-81675 Munich, Germany.
Abstract:
Programmed cell death involves the activation of caspase proteases that can mediate the cleavage of vital cytoskeletal proteins. We have recently reported that, in failing cardiac myocytes, caspase-3 activation is associated with a reduction in contractile performance. In this study we used a modified yeast two-hybrid system to screen for caspase-3 interacting proteins of the cardiac cytoskeleton. We identified ventricular essential myosin light chain (vMLC1) as a target for caspase-3. By sequencing and site-directed mutagenesis, a noncanonical cleavage site for caspase-3 was mapped to the C-terminal DFVE(135)G motif. We demonstrated that vMLC1 cleavage in failing myocardium in vivo is associated with a morphological disruption of the organized vMLC1 staining of sarcomeres, and with a reduction in myocyte contractile performance. Adenoviral gene transfer of the caspase inhibitor p35 in vivo prevented caspase-3 activation and vMLC1 cleavage, with positive impact on contractility. These data suggest that direct cleavage of vMLC1 by activated caspase-3 may contribute to depression of myocyte function by altering cross-bridge interaction between myosin and actin molecules. Therefore, activation of apoptotic pathways in the heart may lead to contractile dysfunction before cell death.
Insights
Activated caspase-3 cleaves ventricular essential myosin light chain (vMLC1) in heart failure, disrupting sarcomeres and reducing contractility. Inhibiting caspase-3 improves cardiac function, suggesting apoptosis contributes to heart dysfunction before cell death.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Programmed cell death involves caspase proteases cleaving cytoskeletal proteins.
- Caspase-3 activation is linked to reduced contractile performance in failing cardiac myocytes.
Purpose of the Study:
- To identify cardiac cytoskeletal proteins interacting with caspase-3.
- To investigate the role of ventricular essential myosin light chain (vMLC1) cleavage in cardiac dysfunction.
Main Methods:
- Modified yeast two-hybrid system screening for caspase-3 interacting proteins.
- Sequencing and site-directed mutagenesis to map vMLC1 cleavage site.
- Adenoviral gene transfer of caspase inhibitor p35 in vivo.
Main Results:
- Ventricular essential myosin light chain (vMLC1) identified as a caspase-3 target at the DFVE(135)G motif.
- vMLC1 cleavage in failing myocardium disrupts sarcomere organization and reduces myocyte contractility.
- p35 inhibition of caspase-3 prevented vMLC1 cleavage and improved cardiac contractility.
Conclusions:
- Direct cleavage of vMLC1 by caspase-3 contributes to cardiac contractile dysfunction.
- Apoptotic pathway activation in the heart can impair myocyte function prior to cell death.